Celularity (CELUW) Payables (2018 - 2025)
Celularity (CELUW) reported Payables of $36.0 million for Q4 2025, up 39.58% year-over-year from $25.8 million in Q4 2024, and up 24.64% quarter-over-quarter from $28.9 million in Q3 2025.
Celularity (CELUW) Payables (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Payables data on file, last reported at $36.0 million in Q4 2025.
- Payables for Q4 2025 came in at $36.0 million, up 39.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $36.0 million (up 39.58% YoY), and the FY2025 annual result was $36.0 million, up 39.58% from the prior year.
- Payables improved to $36.0 million in Q4 2025 per CELUW's latest filing, from $28.9 million in the prior quarter.
- Over five years, Payables peaked at $48.5 million in Q3 2022 and troughed at $5.2 million in Q1 2021.
- A 5-year average of $22.9 million and a median of $26.4 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2021 and 2024: Payables soared 14989.52% in 2021, then tumbled 67.3% in 2024.
- A 5-year view of Payables shows it stood at $9.3 million in 2021, then surged by 365.95% to $43.4 million in 2022, then retreated by 27.75% to $31.4 million in 2023, then decreased by 17.81% to $25.8 million in 2024, then jumped by 39.58% to $36.0 million in 2025.
- Business Quant data shows CELUW's Payables at $36.0 million in Q4 2025, $28.9 million in Q3 2025, and $28.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 35.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.99 Mn |
| Sep 30, 2025 | 28.87 Mn |
| Jun 30, 2025 | 28.70 Mn |
| Mar 31, 2025 | 27.47 Mn |
| Dec 31, 2024 | 25.78 Mn |
| Sep 30, 2024 | 15.40 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 31.37 Mn |
| Sep 30, 2023 | 26.94 Mn |
| Jun 30, 2023 | 29.26 Mn |
| Mar 31, 2023 | 39.70 Mn |
| Dec 31, 2022 | 43.41 Mn |
| Sep 30, 2022 | 48.47 Mn |
| Jun 30, 2022 | 10.23 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | 9.32 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 7.29 Mn |
| Mar 31, 2021 | 5.16 Mn |